Last quarter (Q ), Eterna Therapeutics's total revenue was $21.00K, an increase of Infinity% from the same quarter last year. In Q, Eterna Therapeutics's net income was $-4.52M. See Eterna Therapeutics’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 22	Dec 21	Dec 20
Total Revenue	$ 84.00K	$ 84.00K	$ 84.00K	$ 0.00
Cost of Revenue	-	-	-	-
Gross Profit	$ 84.00K	$ 84.00K	$ 84.00K	-
Operating Expense	$ 13.28M	$ -33.22M	$ -113.55M	$ 7.25M
Operating Income	$ -22.75M	$ -27.23M	$ -107.97M	$ -7.25M
Net Non Operating Interest Income Expense	$ 186.00K	$ 9.85M	-	$ -43.00K
Other Income Expense	$ 806.00K	$ 7.17M	$ 8.57M	$ -19.24M
Pretax Income	$ -21.67M	$ -24.53M	$ -122.30M	$ -26.53M
Tax Provision	$ 54.00K	$ 45.00K	$ 5.00K	$ 0.00
Earnings From Equity Interest Net Of Tax	-	-	-	-
Net Income Common Stockholders	$ -21.75M	$ -24.61M	$ -122.32M	$ -26.53M
Basic EPS	$ -9.74	$ -8.06	$ -2.82	$ -1.51
Diluted EPS	$ -9.74	$ -8.06	$ -2.82	$ -1.51
Basic Average Shares	$ 16.42M	$ 3.05M	$ 43.31M	$ 17.59M
Diluted Average Shares	$ 16.42M	$ 3.05M	$ 43.31M	$ 17.59M
Dividend Per Share	-	-	-	-
Total Operating Income As Reported	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-
Rent Expense Supplemental	-	-	-	-
Total Expenses	$ 13.28M	$ -33.22M	$ -113.55M	$ 7.25M
Net Income From Continuing And Discontinued Operation	$ -21.71M	$ -24.59M	$ -122.31M	$ -26.53M
Normalized Income	$ -11.38M	-	-	$ -7.29M
Interest Expense	$ 10.00K	-	-	$ 43.00K
EBIT	$ -21.95M	$ -24.53M	$ -122.30M	$ -26.49M
EBITDA	$ -17.18M	$ -24.04M	$ -121.84M	$ -26.39M

Currency in USD

Eterna Therapeutics Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing